3 Recruiting Locally Advanced Urothelial Carcinoma Phase 2 Clinical Trials
Active phase 2 studies for locally advanced urothelial carcinoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Locally Advanced Urothelial Carcinoma studiesPhase 2 Studies for Locally Advanced Urothelial Carcinoma
🔵 Active, Not Recruiting Phase1 / Phase2
Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2
Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔